Bayer animal health sale could rake in $8B: report
Bayer animal health sale could rake in $8B: report

20 Mar 2019

Arlene Wb

FIERCE PHARMA

Read More

Lilly`s $7M tax break in Indianapolis draws bipartisan pushback
Lilly`s $7M tax break in Indianapolis draws bipartisan pushback

20 Mar 2019

Eric Sagonowsky

FIERCE PHARMA

Read More

Second U.S. jury finds Bayer`s Roundup caused cancer
Second U.S. jury finds Bayer`s Roundup caused cancer

20 Mar 2019

Tina Bellon

REUTERS

Read More

Sage gets U.S. approval for first postpartum depression therapy
Sage gets U.S. approval for first postpartum depression therapy

20 Mar 2019

Saumya SJ

REUTERS

Read More

FDA Confirms Paragraph IV Patent Challenge of Savaysa 206316 (Edoxaban Tosylate 15 mg, 30 mg and 60 mg) Tablets
FDA Confirms Paragraph IV Patent Challenge of Savaysa 206316 (Edoxaban Tosylate 15 mg, 30 mg and 60 mg) Tablets

19 Mar 2019

FDA

Read More

FDA Confirms Paragraph IV Patent Challenge of Ibrance 207103 (Palbociclib 75 mg, 100 mg and 125 mg) Capsules

FDA Confirms Paragraph IV Patent Challenge of Ibrance 207103 (Palbociclib 75 mg, 100 mg and 125 mg) Capsules

19 Mar 2019

FDA

Read More

Ohio accuses UnitedHealth`s OptumRx of drug overcharges in lawsuit
Ohio accuses UnitedHealth`s OptumRx of drug overcharges in lawsuit

19 Mar 2019

Nate Raymond

REUTERS

Read More

List of New Paragraph IV Certifications as of March 13, 2019
List of New Paragraph IV Certifications as of March 13, 2019

18 Mar 2019

FDA

Read More

FDA Confirms Paragraph IV Patent Challenge of Morphabond ER 206544 (Morphine Sulfate 15 mg, 30 mg, 60 mg and 100 mg) Tablets
FDA Confirms Paragraph IV Patent Challenge of Morphabond ER 206544 (Morphine Sulfate 15 mg, 30 mg, 60 mg and 100 mg) Tablets

18 Mar 2019

FDA

Read More

A Regeneron drug dominates eczema treatment
A Regeneron drug dominates eczema treatment

18 Mar 2019

Adam Feuerstein

STAT NEWS

Read More

PharmaCompass